Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Couch

Showing results (501-510 of 697) with videos related to

Pageof 70
Sort By:
British Journal of Cancer|March 24, 2011
Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2A Osorio, R L Milne, R Alonso, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2012
CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancerMaren Weischer, Børge G Nordestgaard, Paul Pharoah, et al.
NPJ Breast Cancer|February 19, 2025
Lessons learned from a candidate gene study investigating aromatase inhibitor treatment outcome in breast cancerReiner Hoppe, Stefan Winter, Wing-Yee Lo, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 14, 2007
AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a consortium of investigators of modifiers of BRCA1/2 studyFergus J Couch, Olga Sinilnikova, Robert A Vierkant, et al.
Breast Cancer Research : BCR|December 1, 2010
Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2 mutation carriersLogan C Walker, Zachary S Fredericksen, Xianshu Wang, et al.
Human Molecular Genetics|March 25, 2016
Combined genetic and splicing analysis of BRCA1 c.[594-2A>C; 641A>G] highlights the relevance of naturally occurring in-frame transcripts for developing disease gene variant classification algorithmsMiguel de la Hoya, Omar Soukarieh, Irene López-Perolio, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 24, 2016
Genetic Risk Score Mendelian Randomization Shows that Obesity Measured as Body Mass Index, but not Waist:Hip Ratio, Is Causal for Endometrial CancerJodie N Painter, Tracy A O'Mara, Louise Marquart, et al.
Human Molecular Genetics|January 8, 2009
Association of ESR1 gene tagging SNPs with breast cancer riskAlison M Dunning, Catherine S Healey, Caroline Baynes, et al.
Endocrine-Related Cancer|September 3, 2015
Comprehensive genetic assessment of the ESR1 locus identifies a risk region for endometrial cancerTracy A O'Mara, Dylan M Glubb, Jodie N Painter, et al.
Cancer Medicine|April 3, 2018
Genetic overlap between endometriosis and endometrial cancer: evidence from cross-disease genetic correlation and GWAS meta-analysesJodie N Painter, Tracy A O'Mara, Andrew P Morris, et al.
Pageof 70

Showing results (501-510 of 697) with videos related to

Sort By:
Pageof 70
British Journal of Cancer|March 24, 2011
Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2A Osorio, R L Milne, R Alonso, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2012
CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancerMaren Weischer, Børge G Nordestgaard, Paul Pharoah, et al.
NPJ Breast Cancer|February 19, 2025
Lessons learned from a candidate gene study investigating aromatase inhibitor treatment outcome in breast cancerReiner Hoppe, Stefan Winter, Wing-Yee Lo, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 14, 2007
AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a consortium of investigators of modifiers of BRCA1/2 studyFergus J Couch, Olga Sinilnikova, Robert A Vierkant, et al.
Breast Cancer Research : BCR|December 1, 2010
Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2 mutation carriersLogan C Walker, Zachary S Fredericksen, Xianshu Wang, et al.
Human Molecular Genetics|March 25, 2016
Combined genetic and splicing analysis of BRCA1 c.[594-2A>C; 641A>G] highlights the relevance of naturally occurring in-frame transcripts for developing disease gene variant classification algorithmsMiguel de la Hoya, Omar Soukarieh, Irene López-Perolio, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 24, 2016
Genetic Risk Score Mendelian Randomization Shows that Obesity Measured as Body Mass Index, but not Waist:Hip Ratio, Is Causal for Endometrial CancerJodie N Painter, Tracy A O'Mara, Louise Marquart, et al.
Human Molecular Genetics|January 8, 2009
Association of ESR1 gene tagging SNPs with breast cancer riskAlison M Dunning, Catherine S Healey, Caroline Baynes, et al.
Endocrine-Related Cancer|September 3, 2015
Comprehensive genetic assessment of the ESR1 locus identifies a risk region for endometrial cancerTracy A O'Mara, Dylan M Glubb, Jodie N Painter, et al.
Cancer Medicine|April 3, 2018
Genetic overlap between endometriosis and endometrial cancer: evidence from cross-disease genetic correlation and GWAS meta-analysesJodie N Painter, Tracy A O'Mara, Andrew P Morris, et al.
Pageof 70